Mechanisms of muscle wasting in sarcopenia

Revista Brasileira de Reumatologia

Volumn 52, Issue 2, 2012, Pages 247-253

  Teixeira, Vivian de Oliveira Nunes ^a   Filippin, Lidiane Isabel ^b   Xavier, Ricardo Machado ^c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b CENTRO UNIVERSITÁRIO FRANCISCANO   (Brazil)

^c SHIMANE UNIVERSITY   (Japan)

Author keywords

Inflammation; Muscular atrophy; Regeneration; Rheumatoid arthritis

Indexed keywords

CALPAIN; CASPASE; MUSCLE PROTEIN; PROTEASOME;

ANTHROPOMETRY; APOPTOSIS; AUTOPHAGOSOME; AUTOPHAGY; BIOSYNTHESIS; BONE DENSITOMETRY; CATABOLISM; CELL LOSS; CHRONIC ARTHRITIS; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; ECHOGRAPHY; ENZYME ACTIVITY; FUNCTIONAL DISEASE; HUMAN; IMPEDANCE; MOLECULAR MECHANICS; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE METABOLISM; MUSCLE REGENERATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; REVIEW; RHEUMATOID ARTHRITIS; SKELETAL MUSCLE SATELLITE CELL; MUSCLE DISEASE; WASTING SYNDROME;

ARTHRITIS, RHEUMATOID; AUTOPHAGY; HUMANS; MUSCULAR DISEASES; PROTEASOME ENDOPEPTIDASE COMPLEX; SARCOPENIA; WASTING SYNDROME;

EID: 84859304206     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Kinne RW, Brauer R, Stuhlmuller B, Palombo-Kinne E, Burmester GR. Macrophages in rheumatoid arthritis. Arthritis Res 2000; 2(3):189-202.
2. Senna ER, De Barros AL, Silva EO, Costa IF, Pereira LV, Ciconelli RM et al. Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol 2004; 31(3):594-597.
3. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001; 358(9285):903-911.
4. Rocha OMd, Batista AdAP, Maestá N, Burini RC, Laurindo IMM. Sarcopenia da caquexia reumatoide: conceituação, mecanismos, consequências clínicas e tratamentos possíveis. Rev Bras Reumatol 2009; 49(3):288-301.
5. Doherty TJ. Invited review: Aging and sarcopenia. J Appl Physiol 2003; 95(4):1717-1727.
6. Matschke V, Murphy P, Lemmey AB, Maddison P, Thom JM. Skeletal Muscle Properties in Rheumatoid Arthritis Patients. Medicine & Science in Sports & Exercise 2010; 42(12):2149-155.
7. Rall LC, Roubenoff R. Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions. Rheumatology 2004; 43(10):1219-1223.
8. Silva TAA, Frisoli Junior A, Pinheiro MM, Szejnfeld VL. Sarcopenia associada ao envelhecimento: aspectos etiológicos e opções terapêuticas. Rev Bras Reumatol [Review] 2006; 46(6):391-397.
9. Ashwell M, Chinn S, Stalley S, Garrow JS. Female fat distribution - A simple classification based on 2 circumference measurements. International Journal of Obesity 1982; 6(2):143-152.
10. Calura E, Cagnin S, Raffaello A, Laveder P, Lanfranchi G, Romualdi C. Meta-analysis of expression signatures of muscle atrophy: gene interaction networks in early and late stages. BMC Genomics 2008;9.
11. DeBoer MD. Animal models of anorexia and cachexia. Expert Opinion on Drug Discovery [Review] 2009; 4(11):1145-155.
12. Murton AJ, Constantin D, Greenhaff PL. The involvement of the ubiquitin proteasome system in human skeletal muscle remodeling and atrophy. Biochimica Et Biophysica Acta-Molecular Basis of Disease 2008; 1782(12):730-743.
13. Dupont-Versteegden EE. Apoptosis in skeletal muscle and its relevance to atrophy. World Journal of Gastroenterology 2006; 12(46):7463-7466.
14. Primeau AJ, Adhihetty PJ, Hood DA. Apoptosis in heart and skeletal muscle. Canadian Journal of Applied Physiology-Revue Canadienne De Physiologie Appliquee 2002; 27(4):349-395.
15. Cande C, Vahsen N, Garrido C, Kroemer G. Apoptosis-inducing factor (AIF): caspase-independent after all. Cell Death and Differentiation 2004; 11(6):591-595.
16. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis. Annual Review of Biochemistry 1999; 68:383-424.
17. Garrido C, Kroemer G. Lifes smile, deaths grin: vital functions of apoptosis-executing proteins. Current Opinion in Cell Biology. 2004; 16(6):639-646.
18. Bruusgaard JC, Gundersen K. In vivo time-lapse microscopy reveals no loss of murine myonuclei during weeks of muscle atrophy. Journal of Clinical Investigation 2008; 118(4):1450-1457.
19. Hasselgren PO, Wray C, Mammen J. Molecular regulation of muscle cachexia: It may be more than the proteasome. Biochemical and Biophysical Research Communications 2002; 290(1):1-10.
20. Purintrapiban J, Wang MC, Forsberg NE. Degradation of sarcomeric and cytoskeletal proteins in cultured skeletal muscle cells. Comparative Biochemistry and Physiology B-Biochemistry & Molecular Biology 2003; 136(3):393-401.
21. Powers SK, Kavazis AN, DeRuisseau KC. Mechanisms of disuse muscle atrophy: role of oxidative stress. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2005; 288(2):R337-R44.
22. Lum JJ, DeBerardinis RJ, Thompson CB. Autophagy in metazoans: Cell survival in the land of plenty. Nature Reviews Molecular Cell Biology 2005; 6(6):439-448.
23. Bechet D, Tassa A, Taillandier D, Cornbaret L, Attaix D. Lysosomal proteolysis in skeletal muscle. International Journal of Biochemistry & Cell Biology 2005; 37(10):2098-2114.
24. Goll DE, Neti G, Mares SW, Thompson VF. Myofibrillar protein turnover: The proteasome and the calpains. J Anim Sci 2008; 86(14 suppl):E19-E35.
25. Mordier S, Deval C, Bechet D, Tassa A, Ferrara M. Leucine limitation induces autophagy and activation of lysosome-dependent proteolysis in C2C12 myotubes through a mammalian target of rapamycinindependent signaling pathway. Journal of Biological Chemistry 2000; 275(38):29900-29906.
26. Mizushima N, Yamamoto A, Matsui M, Yoshimori T, Ohsumi Y. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Molecular Biology of the Cell 2004; 15(3):1101-1111.
27. Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. Faseb Journal 2004; 18(1):39-51.
28. Sacheck JM, Hyatt JPK, Raffaello A, Jagoe RT, Roy RR, Edgerton VR et al. Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. Faseb Journal 2007; 21(1):140-155.
29. Nakatogawa H, Suzuki K, Kamada Y, Ohsumi Y. Dynamics and diversity in autophagy mechanisms: lessons from yeast. Nature Reviews Molecular Cell Biology. 2009; 10(7):458-467.
30. Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P et al. FOXO3 controls autophagy in skeletal muscle in vivo. Cell Metabolism 2007; 6(6):458-471.
31. Li H, Malhotra S, Kumar A. Nuclear factor-kappa B signaling in skeletal muscle atrophy. Journal of Molecular Medicine-Jmm 2008; 86(10):1113-1126.
32. Wohlgemuth SE, Seo AY, Marzetti E, Lees HA, Leeuwenburgh C. Skeletal muscle autophagy and apoptosis during aging: Effects of calorie restriction and life-long exercise. Experimental Gerontology 2010; 45(2):138-148.
33. Goll DE, Thompson VF, Li HQ, Wei W, Cong JY. The calpain system. Physiological Reviews 2003; 83(3):731-801.
34. Koh TJ, Tidball JG. Nitric oxide inhibits calpain-mediated proteolysis of talin in skeletal muscle cells. American Journal of Physiology-Cell Physiology 2000; 279(3):C806-C812.
35. Goll DE, Dayton WR, Singh I, Robson RM. Studies of the alphaactinin actin interaction in the Z-disk by using calpain. Journal of Biological Chemistry 1991; 266(13):8501-8510.
36. Goll DE, Thompson VF, Taylor RG, Zalewska T. Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin. Bioessays 1992; 14(8):549-556.
37. Du J, Wang XN, Miereles C, Bailey JL, Debigare R, Zheng B et al. Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. Journal of Clinical Investigation 2004; 113(1):115-123.
38. Naujokat C, Fuchs D, Berges C. Adaptive modification and flexibility of the proteasome system in response to proteasome inhibition. Biochimica Et Biophysica Acta-Molecular Cell Research 2007; 1773:1389-1397.
39. Naujokat C, Hoffmann S. Role and function of the 26S proteasome in proliferation and apoptosis. Laboratory Investigation 2002; 82(8):965-980.
40. Wolf DH, Hilt W. The proteasome: a proteolytic nanomachine of cell regulation and waste disposal. Biochimica Et Biophysica Acta- Molecular Cell Research 2004; 1695(1/3):19-31.
41. Li YP, Chen YL, Li AS, Reid MB. Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes. American Journal of Physiology-Cell Physiology 2003; 285(4):C806-C812.
42. Hasselgren PO, Wray C, Mammen J. Molecular regulation of muscle cachexia: it may be more than the proteasome. Biochem Biophys Res Commun 2002; 290(1):1-10.
43. Koncarevic A, Jackman RW, Kandarian SC. The ubiquitin-protein ligase Nedd4 targets Notch1 in skeletal muscle and distinguishes the subset of atrophies caused by reduced muscle tension. Faseb Journal 2007; 21(2):427-437.
44. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001; 294(5547):1704-1708.
45. Centner T, Yano J, Kimura E, McElhinny AS, Pelin K, Witt CC et al. Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain. J Mol Biol 2001; 306(4):717-726.
46. Wang K, McClure J, Tu A. Titin: major myofibrillar components of striated muscle. Proc Natl Acad Sci U S A 1979; 76(8):3698-3702.
47. Lecker SH, Solomon V, Mitch WE, Goldberg AL. Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. Journal of Nutrition 1999; 129(1):227S-237S.
48. Tawa NE Jr, Odessey R, Goldberg AL. Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles. J Clin Invest 1997; 100(1):197-203.
49. Rennie MJ, Selby A, Atherton P, Smith K, Kumar V, Glover EL et al. Facts, noise and wishful thinking: muscle protein turnover in aging and human disuse atrophy. Scandinavian Journal of Medicine & Science in Sports 2010; 20(1):5-9.
50. Rajkumar SV, Richardson PG, Hideshima T, Anderson KC. Proteasome inhibition as a novel therapeutic target in human cancer. Journal of Clinical Oncology 2005; 23(3):630-639.
51. Jackman RW, Kandarian SC. The molecular basis of skeletal muscle atrophy. American Journal of Physiology-Cell Physiology 2004; 287(4):C834-C843.
52. Filippin LI, Vencelino R, Marroni NP, Xavier RM. Influência de processos redox na resposta inflamatória da artrite reumatoide. Rev Bras Reumatol 2008; 48(1):17-24.
53. Moresi V, Williams AH, Meadows E, Flynn JM, Potthoff MJ, McAnally J et al. Myogenin and Class II HDACs Control Neurogenic Muscle Atrophy by Inducing E3 Ubiquitin Ligases. Cell 2010; 143(1):35-45.
54. Cassano M, Quattrocelli M, Crippa S, Perini I, Ronzoni F, Sampaolesi M. Cellular mechanisms and local progenitor activation to regulate skeletal muscle mass. Journal of Muscle Research and Cell Motility 2009; 30(7/8):243-253.
55. Morgan JE, Partridge TA. Muscle satellite cells. Int J Biochem Cell Biol 2003; 35(8):1151-1156.
56. Filippin LI, Cuevas MJ, Lima E, Marroni NP, Gonzalez-Gallego J, Xavier RM. Nitric oxide regulates the repair of injured skeletal muscle. Nitric Oxide 2011; 24(1):43-49.
57. Yamada M, Sankoda Y, Tatsumi R, Mizunoya W, Ikeuchi Y, Sunagawa K et al. Matrix metalloproteinase-2 mediates stretchinduced activation of skeletal muscle satellite cells in a nitric oxidedependent manner. Int J Biochem Cell Biol 2008; 40(10):2183-2191.
58. Berkes CA, Tapscott SJ. MyoD and the transcriptional control of myogenesis. Seminars in Cell & Developmental Biology 2005; 16(4/5):585-595.
59. Massimino ML, Rapizzi E, Cantini M, DallaLibera L, Mazzoleni F, Arslan P et al. ED2+ macrophages increase selectively myoblast proliferation in muscle cultures. Biochemical and Biophysical Research Communications 1997; 235(3):754-759.
60. Chen SE, Jin BW, Li YP. TNF-alpha regulates myogenesis and muscle regeneration by activating p38 MAPK. American Journal of Physiology-Cell Physiology 2007; 292(5):C1660-C1671.
61. Warren GL, Hulderman T, Jensen N, McKinstry M, Mishra M, Luster MI et al. Physiological role of tumor necrosis factor alpha in traumatic muscle injury. Faseb Journal 2002; 16(10):1630.
62. Filippin LI, Moreira AJ, Marroni NP, Xavier RM. Nitric oxide and repair of skeletal muscle injury. Nitric Oxide-Biology and Chemistry 2009; 21(3/4):157-163.
63. Granado M, Martin AI, Priego T, Lopez-Calderon A, Villanua MA. Tumour necrosis factor blockade did not prevent the increase of muscular muscle RING finger-1 and muscle atrophy F-box in arthritic rats. Journal of Endocrinology 2006; 191(1):319-326.
64. Castillero E, Martin AI, Lopez-Menduina M, Granado M, Villanua MA, Lopez-Calderon A. IGF-I system, atrogenes and myogenic regulatory factors in arthritis induced muscle wasting. Molecular and Cellular Endocrinology 2009; 309(1/2):8-16.